Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-trace').style.display = (document.getElementById('cakeErr67ff72efaa36c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ff72efaa36c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-code').style.display = (document.getElementById('cakeErr67ff72efaa36c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-context').style.display = (document.getElementById('cakeErr67ff72efaa36c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ff72efaa36c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ff72efaa36c-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26016,
		&#039;title&#039; =&gt; &#039;Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674054,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26016,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26016,
	&#039;title&#039; =&gt; &#039;Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674054,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26016
$metaTitle = &#039;LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;
$metaKeywords = &#039;Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health&#039;
$metaDesc = &#039;
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee | Im4change.org</title>
    <meta name="description" content="
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.</p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.</p><p align="justify">Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.</p><p align="justify">NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.</p><p align="justify">In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.</p><p align="justify">In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).</p><p align="justify">The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.</p><p align="justify">&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.</p><p align="justify">The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.</p><p align="justify">&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.</p><p align="justify">Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;</p><p align="justify">The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-trace').style.display = (document.getElementById('cakeErr67ff72efaa36c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ff72efaa36c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-code').style.display = (document.getElementById('cakeErr67ff72efaa36c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-context').style.display = (document.getElementById('cakeErr67ff72efaa36c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ff72efaa36c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ff72efaa36c-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26016,
		&#039;title&#039; =&gt; &#039;Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674054,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26016,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26016,
	&#039;title&#039; =&gt; &#039;Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674054,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26016
$metaTitle = &#039;LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;
$metaKeywords = &#039;Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health&#039;
$metaDesc = &#039;
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee | Im4change.org</title>
    <meta name="description" content="
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.</p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.</p><p align="justify">Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.</p><p align="justify">NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.</p><p align="justify">In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.</p><p align="justify">In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).</p><p align="justify">The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.</p><p align="justify">&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.</p><p align="justify">The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.</p><p align="justify">&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.</p><p align="justify">Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;</p><p align="justify">The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-trace').style.display = (document.getElementById('cakeErr67ff72efaa36c-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ff72efaa36c-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-code').style.display = (document.getElementById('cakeErr67ff72efaa36c-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ff72efaa36c-context').style.display = (document.getElementById('cakeErr67ff72efaa36c-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ff72efaa36c-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ff72efaa36c-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26016,
		&#039;title&#039; =&gt; &#039;Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674054,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26016,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26016,
	&#039;title&#039; =&gt; &#039;Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674054,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26016
$metaTitle = &#039;LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee&#039;
$metaKeywords = &#039;Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health&#039;
$metaDesc = &#039;
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;MUMBAI: &lt;/em&gt;In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &amp;quot;with immediate effect&amp;quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &amp;quot;direction&amp;quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Although the NPPA&#039;s sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA&#039;s decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &amp;quot;arbitrary implementation of the policy&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &amp;quot;extraordinary circumstances&amp;quot; and in &amp;quot;public interest&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&amp;quot; NPPA said in its latest notification posted on its website.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&amp;quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &amp;quot;We appreciate the government&#039;s decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee | Im4change.org</title>
    <meta name="description" content="
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.</p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.</p><p align="justify">Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.</p><p align="justify">NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.</p><p align="justify">In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.</p><p align="justify">In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).</p><p align="justify">The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.</p><p align="justify">&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.</p><p align="justify">The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.</p><p align="justify">&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.</p><p align="justify">Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;</p><p align="justify">The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26016,
		'title' => 'Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<br />
<em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
</p>
<p align="justify">
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
</p>
<p align="justify">
Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
</p>
<p align="justify">
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.
</p>
<p align="justify">
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.
</p>
<p align="justify">
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
</p>
<p align="justify">
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
</p>
<p align="justify">
&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.
</p>
<p align="justify">
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
</p>
<p align="justify">
&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
</p>
<p align="justify">
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;
</p>
<p align="justify">
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
</p>',
		'credit_writer' => 'The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674054,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26016,
	'metaTitle' => 'LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee',
	'metaKeywords' => 'Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health',
	'metaDesc' => '
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.</p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.</p><p align="justify">Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.</p><p align="justify">NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.</p><p align="justify">In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.</p><p align="justify">In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).</p><p align="justify">The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.</p><p align="justify">&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.</p><p align="justify">The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.</p><p align="justify">&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.</p><p align="justify">Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;</p><p align="justify">The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. </p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26016,
	'title' => 'Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<br />
<em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.
</p>
<p align="justify">
The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.
</p>
<p align="justify">
Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.
</p>
<p align="justify">
NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.
</p>
<p align="justify">
In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.
</p>
<p align="justify">
In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).
</p>
<p align="justify">
The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.
</p>
<p align="justify">
&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.
</p>
<p align="justify">
The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.
</p>
<p align="justify">
&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.
</p>
<p align="justify">
Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;
</p>
<p align="justify">
The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. 
</p>',
	'credit_writer' => 'The Times of India, 24 September, 2014, http://timesofindia.indiatimes.com/business/india-business/Government-curbs-power-of-regulator-to-cap-HIV-cancer-drug-prices/articleshow/43276718.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'government-curbs-power-of-regulator-to-cap-hiv-cancer-drug-prices-rupali-mukherjee-4674054',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674054,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26016
$metaTitle = 'LATEST NEWS UPDATES | Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee'
$metaKeywords = 'Health Expenditure,health issues,healthcare,healthcare in india,Access to Healthcare,medicines,Health'
$metaDesc = '
-The Times of India



MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.


The National...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><br /><em>MUMBAI: </em>In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines.</p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing &quot;with immediate effect&quot; - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government &quot;direction&quot;. The guideline had been issued on May 29, just three days after the Modi government was sworn in.</p><p align="justify">Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled.</p><p align="justify">NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was &quot;arbitrary implementation of the policy&quot;.</p><p align="justify">In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under &quot;extraordinary circumstances&quot; and in &quot;public interest&quot;.</p><p align="justify">In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013).</p><p align="justify">The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action.</p><p align="justify">&quot;In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect,&quot; NPPA said in its latest notification posted on its website.</p><p align="justify">The industry welcomed the move saying that the interpretation of the May guidelines was erroneous.</p><p align="justify">&quot;We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision,&quot; D G Shah, secretary general of Indian Pharmaceutical Alliance, said.</p><p align="justify">Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: &quot;We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal.&quot;</p><p align="justify">The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29. </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee

-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a government "direction". The guideline had been issued on May 29, just three days after the Modi government was sworn in. Although the NPPA's sudden notification does not mention whether it is revoking the price caps which it had announced on 50 anti-diabetic and cardiac drugs in July, the development could have negative fallout, sources said. A wider and more serious impact will be that impending price controls on expensive treatments of cancer, HIV and tuberculosis now stand cancelled. NPPA officials were not available for comment, but sources say the government succumbed to pressure from industry lobbies. The NPPA's decision to impose price controls had been hotly contested; with the industry up in arms against what it said was "arbitrary implementation of the policy". In effect, NPPA has withdrawn guidelines for price control issued under Para 19 of the Drug Prices Control Order (DPCO) 2013, which authorized it to control prices of drugs that are not under the NLEM (National List of Essential Medicines) under "extraordinary circumstances" and in "public interest". In July the NPPA, in a rare invocation of the lesser-used provision, had fixed prices of 50 anti-diabetic and cardiovascular medicines. This was the first time the government had brought drugs, outside the national list of essential medicines, under price control. (Prices of 652 drugs under NLEM were fixed by the government last year under DPCO 2013). The move had triggered of a series of protests and lawsuits from the industry against the drug pricing regulator as they feared more such action. "In compliance with the directions received from the government in the department of pharmaceuticals ... The aforesaid internal guidelines issued by the NPPA on May 29, 2014 under Paragraph 19 of DPCO 2013 are hereby withdrawn with immediate effect," NPPA said in its latest notification posted on its website. The industry welcomed the move saying that the interpretation of the May guidelines was erroneous. "We have always contended that the guidelines for Para 19 were erroneous. Para 19 is not the right provision for extension of price control as there is no public health concern which could have prompted the NPPA to invoke the provision," D G Shah, secretary general of Indian Pharmaceutical Alliance, said. Though it is still trying to figure out its implication on companies, the industry body representing multinational firms, the Organisation of Pharmaceutical Producers of India, said: "We appreciate the government's decision to withdraw the guidelines on fixation/revision of prices of scheduled and non-scheduled formulations under Para 19 of the DPCO 2013. This welcome move tells us we are being heard and we look forward to working with the government toward a common goal." The industry expects that the NPPA will take a decision on whether to revoke the price reduction order, over the next few days. The next hearing of the OPPI court case against NPPA is slated for September 29.